List of works - Elaine Tierney

A placebo-controlled trial of simvastatin therapy in Smith-Lemli-Opitz syndrome.

scientific article published on 11 August 2016

A prospective open trial of guanfacine in children with pervasive developmental disorders

scientific article published in October 2006

Acute and long-term safety and tolerability of risperidone in children with autism

scientific article

An exploration of concomitant psychiatric disorders in children with autism spectrum disorder

scientific article published on 06 November 2018

Assessment of the integrity of study blindness in a pediatric clinical trial of risperidone

scientific article

Brief Report: social disability in autism spectrum disorder: results from Research Units on Pediatric Psychopharmacology (RUPP) Autism Network trials

scientific article published on March 2013

Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders

scientific article published in September 2006

Children's Yale-Brown obsessive compulsive scale in autism spectrum disorder: component structure and correlates of symptom checklist

scientific article published on 17 October 2013

Cognitive effects of risperidone in children with autism and irritable behavior

scientific article

Dietary status and impact of risperidone on nutritional balance in children with autism: a pilot study

scientific article published in December 2006

Effects of short- and long-term risperidone treatment on prolactin levels in children with autism

scientific article published on 30 May 2006

Examination of aggression and self-injury in children with autism spectrum disorders and serious behavioral problems

scientific article

Exploring the manifestations of anxiety in children with autism spectrum disorders

scientific article

Gastrointestinal symptoms in a sample of children with pervasive developmental disorders

scientific article published on 13 September 2008

No Apparent Cardiac Conduction Effects of Acute Treatment with Risperidone in Children with Autism Spectrum Disorder

scientific article

Parent satisfaction in a multi-site acute trial of risperidone in children with autism: a social validity study

scientific article published on 23 November 2006

Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials

scientific article published in December 2003

Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning

scientific article published on 3 August 2007

Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures

scientific article published in February 2007

Positive effects of methylphenidate on social communication and self-regulation in children with pervasive developmental disorders and hyperactivity

scientific article

Possible influence of variant of the P-glycoprotein gene (MDR1/ABCB1) on clinical response to guanfacine in children with pervasive developmental disorders and hyperactivity

scientific article

Research knowledge among parents of children participating in a randomized clinical trial

scientific article published in February 2005

Risperidone and adaptive behavior in children with autism

scientific article published in April 2006

Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology

scientific article published in June 2005

Risperidone in children with autism and serious behavioral problems

scientific article

Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13.

scientific article published on 9 November 2011

Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial

scientific article

Using a Patient-Centered Outcome Measure to Test Methylphenidate Versus Placebo in Children with Autism Spectrum Disorder

scientific article published on 28 November 2016

Validity of the autism diagnostic interview-revised

scientific article published in May 2006

Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data

scientific article

List of works by Elaine Tierney

A placebo-controlled trial of simvastatin therapy in Smith-Lemli-Opitz syndrome.

A prospective open trial of guanfacine in children with pervasive developmental disorders

Acute and long-term safety and tolerability of risperidone in children with autism

An exploration of concomitant psychiatric disorders in children with autism spectrum disorder

Assessment of the integrity of study blindness in a pediatric clinical trial of risperidone

Brief Report: social disability in autism spectrum disorder: results from Research Units on Pediatric Psychopharmacology (RUPP) Autism Network trials

Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders

Children's Yale-Brown obsessive compulsive scale in autism spectrum disorder: component structure and correlates of symptom checklist

Cognitive effects of risperidone in children with autism and irritable behavior

Dietary status and impact of risperidone on nutritional balance in children with autism: a pilot study

Effects of short- and long-term risperidone treatment on prolactin levels in children with autism

Examination of aggression and self-injury in children with autism spectrum disorders and serious behavioral problems

Exploring the manifestations of anxiety in children with autism spectrum disorders

Gastrointestinal symptoms in a sample of children with pervasive developmental disorders

No Apparent Cardiac Conduction Effects of Acute Treatment with Risperidone in Children with Autism Spectrum Disorder

Parent satisfaction in a multi-site acute trial of risperidone in children with autism: a social validity study

Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials

Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning

Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures

Positive effects of methylphenidate on social communication and self-regulation in children with pervasive developmental disorders and hyperactivity

Possible influence of variant of the P-glycoprotein gene (MDR1/ABCB1) on clinical response to guanfacine in children with pervasive developmental disorders and hyperactivity

Research knowledge among parents of children participating in a randomized clinical trial

Risperidone and adaptive behavior in children with autism

Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology

Risperidone in children with autism and serious behavioral problems

Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13.

Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial

Using a Patient-Centered Outcome Measure to Test Methylphenidate Versus Placebo in Children with Autism Spectrum Disorder

Validity of the autism diagnostic interview-revised

Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data